Skip to main content

Table 1 Participant characteristics of 57 nurses and physicians in oncology/haematology

From: Are cancer patients better off if they participate in clinical trials? A mixed methods study

 Nurse (%) (n = 31)Physician (%) (n = 26)Total (%) (n = 57)
Country
 Denmark19 (61,3)17 (65,4)36 (63,1)
 Sweden12 (38,7)9 (34,6)21 (36,9)
Sex
 Female29 (93,5)18 (69,2)47 (82,5)
 Male2 (6,5)8 (30,8)9 (17,5)
Age
 ≤ 30–3911 (35,8)8 (30,8)18 (33,3)
 40–4910 (32,1)11 (42,3)22 (38,6)
 ≤ 50–5910 (32,1)7 (26,9)17 (29,7)
Education
 Bachelor (3 years)22 (71,0)22 (38,6)
 Specialist nurses9 (29,0)9 (15,7)
 Physicians (≥5 years)9 (34,6)9 (15,7)
 PhD17 (65,4)17 (29,8)
Years as nurse/physician
 Mean14,9 (0,3 to 35)16,4 (1 to15,5 (0,3 to
 ≤ 1013 (42,0)8 (30,7)21 (36,0)
 > 107 (22,5)9 (34,6)16 (28,0)
 > 2011(35,5)9 (34,6)20 (36,0)
Years in oncology/ haematology
 Mean11,2 (0,3 to 35)7,4 (1 to 40)9,5 (0,3 to 40)
 ≤ 1017 (54,8)13 (50,0)30 (52,6)
 > 108 (25,8)7 (27,0)15 (26,3)
 > 206 (19,3)6 (23,0)12 (21,1)
Clinical trial setting
 Phase I13 (41,9)11 (42,3)24 (42,1)
 Phase II14 (41,1)16 (61,5)30 (52,6)
 Phase III27 (87,0)24 (92,3)51 (89,5)
\